Sentences with phrase «based pharmacogenomics»

I continued working at the interface of science and epidemiology, first with Genaissance Pharmaceuticals, a New Haven - based pharmacogenomics company, where I was involved in the fascinating study of human genetic variation and population genetics.

But as the Mason, Ohio - based pharmacogenomics company mushroomed from one table to three offices, it became harder to keep a handle on the company culture.

Not exact matches

The Silvio O. Conte Center, a multi-institutional effort based at the University of Chicago, will combine the statistical power of pre-existing genetics, pharmacogenomics, text - mining, and clinical record databases to confront diseases that have so far frustrated researchers.

In furtherance of their mutual interest in improving fundamental and clinical pharmacogenomics and its translation into clinical practice, the two organizations have agreed: (a) cooperate and collaborate on programs and activities of mutual interest, (b) work together to provide education symposia / workshops in developing countries and regions, and (c) foster collaborative research to better understand the genetic basis for ethnic diversity in the response to and adverse effects from medicines.

With its uniquely comprehensive population data, deCODE is turning research on the genetic causes of common diseases into a growing range of products and services — in gene discovery, pharmaceuticals, DNA - based diagnostics, pharmacogenomics, in silico discovery tools, bioinformatics and medical decision support systems.

The Sections aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and genomics, to evaluate the clinical impact of pharmacogenetics, to assist with the development and maintenance of drug - related pharmacogenetic databases and to create a population based biobank to conduct translational research in clinical pharmacogenomics.

For example, it is used to identify correlations between gene sequences and diseases, to predict protein structures from amino acid sequences, to aid in the design of novel drugs, and to tailor treatments to individual patients based on their DNA sequences (pharmacogenomics).

There were also lectures about evidence - based dosing based on genotype, by the KNMP Pharmacogenomics Working Group (Dr. Vera Deneer, den Haag, the Netherlands) and the European Medicine Agency Pharmacogenomics Working Party (Dr. Norma Anwar, London, UK).

Pharmacogenomics Knowledge Base; curated and annotated information regarding the effects of human genetic variations on drug response.

With its uniquely comprehensive population data, deCODE is turning research on the genetic causes of common diseases into a growing pipeline of products and services — in pharmaceuticals, gene and drug discovery, DNA - based diagnostics, pharmacogenomics, bioinformatics, and clinical trials.

Author, «FDA Approval of BiDil: First Step to Pharmacogenomics or Detour into Race - based Medicine?»